A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome
Clinical trial NCT03098797 · COMPLETED
Trial details
- NCT number
- NCT03098797
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2018-10-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.